Clinical Trial Update: Dermoscopy vs Standard Marking for the Completeness of Excision of Keratinocyte Skin Cancers: The ClearMark Trial [Phase 4]

View source ↗

Summary

Clinical trial update for The ClearMark Trial, a Phase 4 study comparing dermoscopy with standard marking to assess the completeness of excision for keratinocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Squamous Cell Carcinoma of the Skin

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Keratinocyte Skin Cancer | Phase 4 | Status: RECRUITING